Physician profile
Scott A Mcwilliams
NPI 1013918812
$12,097.68
in general payments reported to CMS, 2019-2025
62 companies · $2,441 in 2025
The $2,441 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $1,404 · 2021: $1,687 · 2022: $1,964 · 2023: $1,607 · 2024: $2,109 · 2025: $2,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,157.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,893.84 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $914.05 | 2019-2025 | |
| Allergan, INC. | $847.94 | 2019-2022 | |
| Lundbeck LLC | $834.52 | 2020-2025 | Vyepti, Rexulti |
| Biogen, INC. | $727.85 | 2019-2025 | Vumerity, Plegridy, Tysabri |
| Amneal Pharmaceuticals LLC | $585.05 | 2020-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Argenx US, INC. | $500.37 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Ucb, INC. | $476.13 | 2019-2025 | Rystiggo, Fintepla, Briviact |
| Sunovion Pharmaceuticals INC. | $391.58 | 2019-2022 | |
| Lilly USA, LLC | $336.98 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Acorda Therapeutics, INC | $300.32 | 2020-2024 | Inbrija |
| Amgen INC. | $288.24 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $286.87 | 2019-2025 | Nuplazid |
| Upsher-Smith Laboratories LLC | $264.73 | 2020-2023 | |
| Grifols USA, LLC | $248.11 | 2020-2025 | Gamunex-C |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mcwilliams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.